Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...

Atrazine, a widely used herbicide in the U.S., was recently classified as “probably carcinogenic” by the WHO’s IARC, potentially fueling new lawsuits. This raises legal questions about how courts ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

View post: 1981 Hit Film Was Just Ranked the 'Most Exciting Action Thriller of All Time' ...